Adding an experimental messenger RNA (mRNA)-based vaccine from Moderna Inc and Merck & Co reduced the risk that the most deadly skin cancer would spread by 65 percent over treatment with an immunotherapy alone in a mid-stage trial, the companies reported on Monday.
With this and earlier data, Moderna is considering seeking faster approval from regulators for the treatment, the company told investors after having presented the results at the American Society of Clinical Oncology meeting in Chicago.
“Some of the residual uncertainty seems to be going away on that potential [option],” Moderna president Stephen Hoge said.
The data followed earlier promising data from the trial showing the customized mRNA vaccine given in combination with Merck’s Keytruda cut the risk of death or recurrence of melanoma by 44 percent compared with Keytruda alone.
The findings add to a growing body of evidence suggesting that mRNA technology, which rose to prominence during the COVID-19 pandemic, can be used to assemble personalized vaccines that train the immune system to attack the specific type of cancer cells in a patient’s tumors.
Scientists have been chasing the dream of vaccines to treat cancer for decades with few successes.
Experts say mRNA vaccines, which can be produced in as little as eight weeks, paired with drugs that rev up the immune system might lead to a new generation of cancer therapies.
The hope is for “a completely new treatment paradigm in cancer that will be better tolerated and unique to individual patients’ tumors,” said Jane Healy, an executive overseeing in early cancer treatment development at Merck.
Moderna said during its investor call that it was starting a phase 3 confirmatory study, which it hoped to open in the third quarter of this year.
The Merck/Moderna collaboration is one of several combining powerful drugs that unleash the immune system to target cancers with mRNA vaccine technology.
Pfizer’s COVID-19 vaccine partner BioNTech SE and Gritstone Bio Inc are taking similar approaches using mRNA technology.
The vaccines all target neoantigens, new mutations that are only present on tumors. Aiming at these unique proteins allows the immune system to kill cancer cells, while leaving healthy tissue unscathed.
The trick is determining which of many mutations is driving the cancer. To accomplish this, tumors are removed and their genetic makeup is mapped using next-generation DNA sequencing. Companies use artificial intelligence to predict which mutations will be the most effective targets.
These are used to build an individualized vaccine targeting only mutations in the patient’s tumor.
During this process, patients typically receive an immunotherapy such as Keytruda or Roche’s Tecentriq, which block a mechanism cancer uses to hide from the immune system.
Long before COVID-19, companies had been eyeing mRNA technology, which carries instructions for cells to make specific proteins, as a vehicle for delivering a cancer vaccine.
A new online voting system aimed at boosting turnout among the Philippines’ millions of overseas workers ahead of Monday’s mid-term elections has been marked by confusion and fears of disenfranchisement. Thousands of overseas Filipino workers have already cast their ballots in the race dominated by a bitter feud between President Ferdinand Marcos Jr and his impeached vice president, Sara Duterte. While official turnout figures are not yet publicly available, data from the Philippine Commission on Elections (COMELEC) showed that at least 134,000 of the 1.22 million registered overseas voters have signed up for the new online system, which opened on April 13. However,
EUROPEAN FUTURE? Albanian Prime Minister Edi Rama says only he could secure EU membership, but challenges remain in dealing with corruption and a brain drain Albanian Prime Minister Edi Rama seeks to win an unprecedented fourth term, pledging to finally take the country into the EU and turn it into a hot tourist destination with some help from the Trump family. The artist-turned-politician has been pitching Albania as a trendy coastal destination, which has helped to drive up tourism arrivals to a record 11 million last year. US President Donald Trump’s son-in-law, Jared Kushner, also joined in the rush, pledging to invest US$1.4 billion to turn a largely deserted island into a luxurious getaway. Rama is expected to win another term after yesterday’s vote. The vote would
ALLIES: Calling Putin his ‘old friend,’ Xi said Beijing stood alongside Russia ‘in the face of the international counter-current of unilateralism and hegemonic bullying’ Chinese President Xi Jinping (習近平) yesterday was in Moscow for a state visit ahead of the Kremlin’s grand Victory Day celebrations, as Ukraine accused Russia’s army of launching air strikes just hours into a supposed truce. More than 20 foreign leaders were in Russia to attend a vast military parade today marking 80 years since the defeat of Nazi Germany in World War II, taking place three years into Russia’s offensive in Ukraine. Putin ordered troops into Ukraine in February 2022 and has marshaled the memory of Soviet victory against Nazi Germany to justify his campaign and rally society behind the offensive,
CONFLICTING REPORTS: Beijing said it was ‘not familiar with the matter’ when asked if Chinese jets were used in the conflict, after Pakistan’s foreign minister said they were The Pakistan Army yesterday said it shot down 25 Indian drones, a day after the worst violence between the nuclear-armed rivals in two decades. Pakistani Prime Minister Shehbaz Sharif vowed to retaliate after India launched deadly missile strikes on Wednesday morning, escalating days of gunfire along their border. At least 45 deaths were reported from both sides following Wednesday’s violence, including children. Pakistan’s military said in a statement yesterday that it had “so far shot down 25 Israeli-made Harop drones” at multiple location across the country. “Last night, India showed another act of aggression by sending drones to multiple locations,” Pakistan military spokesman Ahmed
RSS